...
首页> 外文期刊>JACC. Cardiovascular interventions >Final 5-Year Follow-Up of a Randomized Controlled Trial of Everolimus-and Paclitaxel-Eluting Stents for Coronary Revascularization in Daily Practice The COMPARE Trial (A Trial of Everolimus-Eluting Stents and Paclitaxel Stents for Coronary Revascularization in Daily Practice)
【24h】

Final 5-Year Follow-Up of a Randomized Controlled Trial of Everolimus-and Paclitaxel-Eluting Stents for Coronary Revascularization in Daily Practice The COMPARE Trial (A Trial of Everolimus-Eluting Stents and Paclitaxel Stents for Coronary Revascularization in Daily Practice)

机译:在日常实践中对依维莫司和紫杉醇洗脱支架进行冠脉血运重建的随机对照试验的最后5年随访COMPARE试验(在日常实践中对依维莫司洗脱支架和紫杉醇支架进行冠脉血运重建的试验)

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVES This study sought to report the 5-year outcomes of everolimus-eluting stents (EES) and paclitaxel-eluting stents (PES) in an all-comers population undergoing percutaneous coronary intervention (PCI).
机译:目的本研究旨在报告在接受经皮冠状动脉介入治疗(PCI)的所有人群中,依维莫司洗脱支架(EES)和紫杉醇洗脱支架(PES)的5年结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号